Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia

被引：83

作者：

Chowdhury, M. ^{[1
]}

Mihara, K.

Yasunaga, S.

Ohtaki, M.

Takihara, Y.

Kimura, A.

机构：

[1] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Div Clin & Expt Oncol,Minamu Ku, Hiroshima 730, Japan

[2] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Stem Cell Biol, Div Radiat & Regenerat Control,Minami Ku, Hiroshima 730, Japan

[3] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Envirometr & Biometr, Div Biomed Informat,Minami Ku, Hiroshima 730, Japan

来源：

LEUKEMIA | 2007年 / 21卷 / 05期

关键词：

D O I：

10.1038/sj.leu.2404623

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1116 / 1122

页数：8

共 8 条

[1] Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461) [J].

Byrd, JC ;

Mrózek, K ;

Dodge, RK ;

Carroll, AJ ;

Edwards, CG ;

Arthur, DC ;

Pettenati, MJ ;

Patil, SR ;

Rao, KW ;

Watson, MS ;

Koduru, PRK ;

Moore, JO ;

Stone, RM ;

Mayer, RJ ;

Feldman, EJ ;

Davey, FR ;

Schiffer, CA ;

Larson, RA ;

Bloomfield, CD .

BLOOD, 2002, 100 (13) :4325-4336

[2] Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J].

Cheson, BD ;

Bennett, JM ;

Kopecky, KJ ;

Büchner, T ;

Willman, CL ;

Estey, EH ;

Schiffer, CA ;

Döhner, H ;

Tallman, MS ;

Lister, TA ;

LoCocco, F ;

Willemze, R ;

Biondi, A ;

Hiddemann, W ;

Larson, RA ;

Löwenberg, B ;

Sanz, MA ;

Head, DR ;

Ohno, R ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4642-4649

[3]

Kiyoi H, 1999, BLOOD, V93, P3074

[4] Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells [J].

Lessard, J ;

Sauvageau, G .

NATURE, 2003, 423 (6937) :255-260

[5] Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis [J].

Mihara, K ;

Chowdhury, M ;

Nakaju, N ;

Hidani, S ;

Ihara, A ;

Hyodo, H ;

Yasunaga, S ;

Takihara, Y ;

Kimura, A .

BLOOD, 2006, 107 (01) :305-308

[6] BMI-1 is highly expressed in MO-subtype acute myeloid leukemia [J].

Sawa, M ;

Yamamoto, K ;

Yokozawa, T ;

Kiyoi, H ;

Hishida, A ;

Kajiguchi, T ;

Seto, M ;

Kohno, A ;

Kitamura, K ;

Itoh, Y ;

Asou, N ;

Hamajima, N ;

Emi, N ;

Naoe, T .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (01) :42-47

[7] Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors [J].

Schnittger, S ;

Wörmann, B ;

Hiddemann, WG ;

Griesinger, F .

BLOOD, 1998, 92 (05) :1728-1734

[8] Polycomb silencers control cell fate, development and cancer [J].

Sparmann, Anke ;

van Lohuizen, Maarten .

NATURE REVIEWS CANCER, 2006, 6 (11) :846-856

← 1 →